Hungarian Translations Citations 1-25 of 26 total displayed. Gastrointestinal Cancer Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, and David D. Chang J. Clin. Oncol. 2008; 26: 1626-1634. [Abstract] [Full text] [PDF] [Hungarian PDF]   Breast Cancer Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer Shannon Puhalla, Ewa Mrozek, Donn Young, Susan Ottman, Anne McVey, Kari Kendra, Nancy J. Merriman, Mark Knapp, Taral Patel, Mark E. Thompson, James F. Maher, Timothy D. Moore, and Charles L. Shapiro J. Clin. Oncol. 2008; 26: 1691-1697. [Abstract] [Full text] [PDF] [Hungarian PDF]   Gastrointestinal Cancer Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer Rafael G. Amado, Michael Wolf, Marc Peeters, Eric Van Cutsem, Salvatore Siena, Daniel J. Freeman, Todd Juan, Robert Sikorski, Sid Suggs, Robert Radinsky, Scott D. Patterson, and David D. Chang J. Clin. Oncol. 2008; 26: 1626-1634. [Abstract] [Full text] [PDF] [Hungarian PDF]   Breast Cancer Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer Shannon Puhalla, Ewa Mrozek, Donn Young, Susan Ottman, Anne McVey, Kari Kendra, Nancy J. Merriman, Mark Knapp, Taral Patel, Mark E. Thompson, James F. Maher, Timothy D. Moore, and Charles L. Shapiro J. Clin. Oncol. 2008; 26: 1691-1697. [Abstract] [Full text] [PDF] [Hungarian PDF]   Thoracic Oncology Reproductive Factors, Hormone Use, Estrogen Receptor Expression and Risk of Non–Small-Cell Lung Cancer in Women Ann G. Schwartz, Angela S. Wenzlaff, Geoffrey M. Prysak, Valerie Murphy, Michele L. Cote, Sam C. Brooks, Debra F. Skafar, and Fulvio Lonardo J. Clin. Oncol. 2007; 25: 5785-5792. [Abstract] [Full text] [PDF] [Hungarian PDF]   Breast Cancer Significance of Multifocality in Ductal Carcinoma In Situ: Outcomes of Women Treated With Breast-Conserving Therapy Eileen Rakovitch, Jean-Philippe Pignol, Wedad Hanna, Steven Narod, Jacqueline Spayne, Sharon Nofech-Mozes, Carole Chartier, and Lawrence Paszat J. Clin. Oncol. 2007; 25: 5591-5596. [Abstract] [Full text] [PDF] [Hungarian PDF]   Editorials Can Biology Trump Anatomy? Do All Node-Positive Patients With Breast Cancer Need Chemotherapy? N. Lynn Henry and Daniel F. Hayes J. Clin. Oncol. 2007; 25: 2501-2503. [Full text] [PDF] [Hungarian PDF]   Breast Cancer Leuprorelin Acetate Every-3-Months Depot Versus Cyclophosphamide, Methotrexate, and Fluorouracil As Adjuvant Treatment in Premenopausal Patients With Node-Positive Breast Cancer: The TABLE Study Peter Schmid, Michael Untch, Valentin Kossé, Grigorij Bondar, Leonid Vassiljev, Valerie Tarutinov, Ute Lehmann, Lutz Maubach, Juergen Meurer, Diethelm Wallwiener, and Kurt Possinger J. Clin. Oncol. 2007; 25: 2509-2515. [Abstract] [Full text] [PDF] [Hungarian PDF]   Gastrointestinal Cancer Identifying Stage III Colorectal Cancer Patients: The Influence of the Patient, Surgeon, and Pathologist Eva Judith Ann Morris, Nicola Joanne Maughan, David Forman, and Philip Quirke J. Clin. Oncol. 2007; 25: 2573-2579. [Abstract] [Full text] [PDF] [Hungarian PDF]   Breast Cancer Poor Outcome of Hormone Receptor–Positive Breast Cancer at Very Young Age Is Due to Tamoxifen Resistance: Nationwide Survival Data in Korea—A Report From the Korean Breast Cancer Society Sei Hyun Ahn, Byung Ho Son, Seok Won Kim, Seung Il Kim, Joon Jeong, Seung-Sang Ko, and Wonshik Han J. Clin. Oncol. 2007; 25: 2360-2368. [Abstract] [Full text] [PDF] [Hungarian PDF]   Radiation Oncology Impact of Adoption of Chemoradiotherapy on the Outcome of Cervical Cancer in Ontario: Results of a Population-Based Cohort Study Robert Pearcey, Qun Miao, Weidong Kong, Jina Zhang-Salomons, and William J. Mackillop J. Clin. Oncol. 2007; 25: 2383-2388. [Abstract] [Full text] [PDF] [Hungarian PDF]   Melanoma Cost Effectiveness of Adjuvant Interferon in Node-Positive Melanoma Janice N. Cormier, Yan Xing, Meichun Ding, Scott B. Cantor, Kristi J. Salter, Jeffrey E. Lee, Paul F. Mansfield, Jeffrey E. Gershenwald, and Merrick I. Ross J. Clin. Oncol. 2007; 25: 2442-2448. [Abstract] [Full text] [PDF] [Hungarian PDF]   ASCO Special Article American Society of Clinical Oncology 2007 Clinical Practice Guideline Update on the Role of Bisphosphonates in Multiple Myeloma Robert A. Kyle, Gary C. Yee, Mark R. Somerfield, Patrick J. Flynn, Susan Halabi, Sundar Jagannath, Robert Z. Orlowski, David G. Roodman, Patricia Twilde, and Kenneth Anderson J. Clin. Oncol. 2007; 25: 2464-2472. [Abstract] [Full text] [PDF] [Hungarian PDF]   Editorials Epidermal Growth Factor Receptor Inhibition in Head and Neck Cancer—More Insights, but More Questions Arlene A. Forastiere and Barbara A. Burtness J. Clin. Oncol. 2007; 25: 2152-2155. [Full text] [PDF] [Hungarian PDF]   Head and Neck Cancer Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer Stephane Temam, Hidetoshi Kawaguchi, Adel K. El-Naggar, Jaroslav Jelinek, Hongli Tang, Diane D. Liu, Wenhua Lang, Jean-Pierre Issa, J. Jack Lee, and Li Mao J. Clin. Oncol. 2007; 25: 2164-2170. [Abstract] [Full text] [PDF] [Hungarian PDF]   Head and Neck Cancer Open-Label, Uncontrolled, Multicenter Phase II Study to Evaluate the Efficacy and Toxicity of Cetuximab As a Single Agent in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Who Failed to Respond to Platinum-Based Therapy Jan B. Vermorken, José Trigo, Ricardo Hitt, Piotr Koralewski, Eduardo Diaz-Rubio, Frédéric Rolland, Rainald Knecht, Nadia Amellal, Armin Schueler, and José Baselga J. Clin. Oncol. 2007; 25: 2171-2177. [Abstract] [Full text] [PDF] [Hungarian PDF]   Head and Neck Cancer Phase I/II Trial of Erlotinib and Cisplatin in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Princess Margaret Hospital Phase II Consortium and National Cancer Institute of Canada Clinical Trials Group Study Lillian L. Siu, Denis Soulieres, Eric X. Chen, Gregory R. Pond, Soo F. Chin, Peggy Francis, Luc Harvey, Meri Klein, Wenjiang Zhang, Janet Dancey, Elizabeth A. Eisenhauer, and Eric Winquist J. Clin. Oncol. 2007; 25: 2178-2183. [Abstract] [Full text] [PDF] [Hungarian PDF]   Editorials Problems With the Progesterone Receptor in Practice? V. Craig Jordan and Richard D. Gelber J. Clin. Oncol. 2007; 25: 1957-1959. [Full text] [PDF] [Hungarian PDF]   Breast Cancer Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17 Paul E. Goss, James N. Ingle, Silvana Martino, Nicholas J. Robert, Hyman B. Muss, Martine J. Piccart, Monica Castiglione, Dongsheng Tu, Lois E. Shepherd, Kathleen I. Pritchard, Robert B. Livingston, Nancy E. Davidson, Larry Norton, Edith A. Perez, Jeffrey S. Abrams, David A. Cameron, Michael J. Palmer, and Joseph L. Pater J. Clin. Oncol. 2007; 25: 2006-2011. [Abstract] [Full text] [PDF] [Hungarian PDF]   Editorials Cutting Back on Computed Tomography Scan Frequency in Curative Oncology: Get the Picture Ronald de Wit J. Clin. Oncol. 2007; 25: 1308-1309. [Full text] [PDF] [Hungarian PDF]   Gastrointestinal Cancer Prognostic and Predictive Roles of High-Degree Microsatellite Instability in Colon Cancer: A National Cancer Institute–National Surgical Adjuvant Breast and Bowel Project Collaborative Study George P. Kim, Linda H. Colangelo, H. Samuel Wieand, Soonmyung Paik, Ilan R. Kirsch, Norman Wolmark, and Carmen J. Allegra J. Clin. Oncol. 2007; 25: 767-772. [Abstract] [Full text] [PDF] [Hungarian PDF]   Breast Cancer Zoledronic Acid Prevents Cancer Treatment–Induced Bone Loss in Premenopausal Women Receiving Adjuvant Endocrine Therapy for Hormone-Responsive Breast Cancer: A Report From the Austrian Breast and Colorectal Cancer Study Group Michael F.X. Gnant, Brigitte Mlineritsch, Gero Luschin-Ebengreuth, Stephan Grampp, Helmut Kaessmann, Marianne Schmid, Christian Menzel, Jutta Claudia Piswanger-Soelkner, Arik Galid, Martina Mittlboeck, Hubert Hausmaninger, and Raimund Jakesz J. Clin. Oncol. 2007; 25: 820-828. [Abstract] [Full text] [PDF] [Hungarian PDF]   Cost-Effectiveness Cost Effectiveness of Adjuvant Trastuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Nicola Lucio Liberato, Monia Marchetti, and Giovanni Barosi J. Clin. Oncol. 2007; 25: 625-633. [Abstract] [Full text] [PDF] [Hungarian PDF]   Editorials Meeting Spiritual Needs: What Is an Oncologist to Do? Betty Ferrell J. Clin. Oncol. 2007; 25: 467-468. [Full text] [PDF] [Hungarian PDF]   Thoracic Oncology Lung Cancer Incidence in Never Smokers Heather A. Wakelee, Ellen T. Chang, Scarlett L. Gomez, Theresa H. Keegan, Diane Feskanich, Christina A. Clarke, Lars Holmberg, Lee C. Yong, Laurence N. Kolonel, Michael K. Gould, and Dee W. West J. Clin. Oncol. 2007; 25: 472-478. [Abstract] [Full text] [PDF] [Hungarian PDF]   Biology of Neoplasia Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer Lecia V. Sequist, Daphne W. Bell, Thomas J. Lynch, and Daniel A. Haber J. Clin. Oncol. 2007; 25: 587-595. [Abstract] [Full text] [PDF] [Hungarian PDF]   ASCO Special Articles American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer Antonio C. Wolff, M. Elizabeth H. Hammond, Jared N. Schwartz, Karen L. Hagerty, D. Craig Allred, Richard J. Cote, Mitchell Dowsett, Patrick L. Fitzgibbons, Wedad M. Hanna, Amy Langer, Lisa M. McShane, Soonmyung Paik, Mark D. Pegram, Edith A. Perez, Michael F. Press, Anthony Rhodes, Catharine Sturgeon, Sheila E. Taube, Raymond Tubbs, Gail H. Vance, Marc van de Vijver, Thomas M. Wheeler, and Daniel F. Hayes J. Clin. Oncol. 2007; 25: 118-145. [Abstract] [Full text] [PDF] [Hungarian PDF]   [Next page] Pages: 1 2